The implementation of high-throughput technologies is necessary in the field of spontaneous preterm birth research. A compelling option is the use of proteomics in the area of spontaneous preterm birth biomarker identification in amniotic fluid, maternal plasma/serum, cervicovaginal fluid and placental tissue.